News
Moreover, Downing Street has indicated that the UK will receive "preferential treatment in any further tariffs imposed" as ...
Shionogi has reached a JPY 151 billion ($1.04 billion) agreement to buy the pharmaceutical subsidiary of Japan Tobacco, Torii ...
That is according to the chief executive of the American Association for the Advancement of Science (AAAS), Sudip Parikh, who ...
Axtria, an AI-first data analytics innovator focused on transforming life sciences, has announced its highly anticipated ...
The GLISTEN trial of GSK's linerixibat has shown that the oral ileal bile acid transporter (IBAT inhibitor was signposted as ...
Cambridge, Massachusetts-based Vor Bio has confirmed that it will halt clinical and manufacturing operations, including its ...
AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi ...
According to Politico, Trump will issue an executive order in the next few days to pursue the use of a so-called 'most ...
AstraZeneca and Daiichi Sankyo's anti-HER2 drug Enhertu has been shown to provide a benefit in a phase 3 trial in early-stage ...
For instance, studies have shown that approximately 25% of adults with diabetes reported rationing insulin in the previous ...
Boehringer Ingelheim has started a proof-of-concept trial of a drug that could offer the first oral treatment for geographic ...
Robert F Kennedy Jr has launched a project to trawl federal databases to try to identify why there has been an increase in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results